John Walker | Chairman and CEO |
Greg Kitchener | CFO |
Don Kellerman | VP, Clinical Development and Medical Affairs |
Hayley Lewis | SVP, Operations |
Charles Duncan | Cantor Fitzgerald |
Anthony Vendetti | Maxim Group |
Bert Hazlett | BTIG |
Good day, ladies and gentlemen, and welcome to the Zosano Pharma Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, today’s conference may be recorded.
I’d now like to introduce your host for today's conference Mr.